Proposed Federal Budget Slashes Funds to EPA, CDC

Funds for the NIH and NSF would stay flat, while some agencies, including the FDA and NASA, would see increases.

Written byDiana Kwon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

PIXABAY, 12019Yesterday (February 12), President Donald Trump’s administration released its proposed budget for fiscal year 2019—just days after Congress passed a deal to increase discretionary spending caps. The proposal calls for cuts to some science agencies, including the Environmental Protection Agency (EPA) and the Centers for Disease Control and Prevention (CDC), while maintaining or boosting funding for others.

Under the proposed budget, funds for the National Science Foundation (NSF) and the National Institutes of Health (NIH) would remain at roughly the same level as in 2017. Trump’s plan also includes adding three new agencies within the NIH, Nature reports: Two existing agencies, the National Institute of Disability, Independent Living, and Rehabilitation Research and the National Institute of Occupational Safety and Health, would be transferred over to the NIH from the Department of Health and Human Services (HHS) and from the CDC, respectively; and a new National Institute for Research on Safety and Quality would replace HHS’s Agency for Healthcare Research and Quality.

“We are. . . concerned that the president’s budget would fold the Agency for Healthcare Research and Quality (AHRQ) into the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies